{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:42:49Z","timestamp":1783507369240,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmii.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T02:23:59Z","timestamp":1674527039000},"page":"634-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1704-1728","authenticated-orcid":false,"given":"Meng-Hsiu","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8391-100X","authenticated-orcid":false,"given":"Dah-Chin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Jan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chien","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhu-Chering","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzou-Yien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2023.01.010_bib1","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jmii.2014.08.003","article-title":"Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: a nationwide surveillance","volume":"48","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2023.01.010_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1348-0421.2001.tb01293.x","article-title":"Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in\u00a0vitro","volume":"45","author":"Okazaki","year":"2001","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jmii.2023.01.010_bib3","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2023.01.010_bib4","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.01684-08","article-title":"Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China","volume":"53","author":"Liu","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2023.01.010_bib5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s10156-012-0523-3","article-title":"Macrolide-resistant mycoplasma pneumoniae in children in taiwan","volume":"19","author":"Wu","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2023.01.010_bib6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ppul.22706","article-title":"Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan","volume":"48","author":"Wu","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jmii.2023.01.010_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","article-title":"Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter?","volume":"52","author":"Yang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2023.01.010_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","article-title":"Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children","volume":"2010-2019","author":"Lee","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2023.01.010_bib9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jfma.2019.12.008","article-title":"Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant Mycoplasma pneumoniae in children in Taiwan","author":"Lu","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2023.01.010_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1442-200X.2010.03316.x","article-title":"Japanese guidelines for the management of respiratory infectious diseases in children 2007 with focus on pneumonia","volume":"53","author":"Uehara","year":"2011","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jmii.2023.01.010_bib11","unstructured":"Pediatric Infectious Diseases Society of Taiwan. Recommendations for the management of community-acquired pneumonia in children. https:\/\/www.pids.org.tw\/index.php?route=news\/news_detail&news_id=93."},{"key":"10.1016\/j.jmii.2023.01.010_bib12","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1099\/jmm.0.066191-0","article-title":"Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK","volume":"62","author":"Ferguson","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jmii.2023.01.010_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dks457","article-title":"Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection","volume":"68","author":"Principi","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2023.01.010_bib14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.01806-13","article-title":"More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia","volume":"58","author":"Zhou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2023.01.010_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia","volume":"16","author":"Morozumi","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2023.01.010_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cytogfr.2004.01.001","article-title":"Cytokines in Mycoplasma pneumoniae infections","volume":"15","author":"Yang","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jmii.2023.01.010_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/adc.78.1.67","article-title":"Analysis of mycoplasmal pleural effusion by the polymerase chain reaction","volume":"78","author":"Narita","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jmii.2023.01.010_bib18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/CDLI.8.5.1028-1030.2001","article-title":"Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection","volume":"8","author":"Narita","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jmii.2023.01.010_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fmicb.2016.00800","article-title":"Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia","volume":"7","author":"Izumikawa","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2023.01.010_bib20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1378\/chest.121.5.1493","article-title":"Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults","volume":"121","author":"Tanaka","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2023.01.010_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jiac.2014.10.008","article-title":"Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jmii.2023.01.010_bib22","first-page":"4","article-title":"The fall of the macrolide : macrolide-resistant mycoplasma pneumoniae","volume":"10","author":"Lung","year":"2014","journal-title":"J Paediatr Respirol Crit Care"},{"key":"10.1016\/j.jmii.2023.01.010_bib23","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3201\/eid2310.170106","article-title":"Macrolide-resistant mycoplasma pneumoniae infection,\u00a0Japan, 2008\u20132015","volume":"23","author":"Tanaka","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2023.01.010_bib24","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","article-title":"Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone","volume":"175","author":"Lee","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jmii.2023.01.010_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12879-017-2500-z","article-title":"Radiologic findings as a determinant and No effect of macrolide resistance on clinical course of mycoplasma pneumoniae pneumonia","volume":"17","author":"Yoon","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.jmii.2023.01.010_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219463","article-title":"Correlation between chest radiographic findings and clinical features in hospitalized children with mycoplasma pneumoniae pneumonia","volume":"14","author":"Cho","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2023.01.010_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jiac.2013.09.009","article-title":"Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:29:46Z","timestamp":1761658186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118223000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1684118223000105"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2023.01.010","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}